Kathleen A. Rickard is Chief Medical Officer of Verona Pharma plc. Currently has a direct ownership of 0 shares of VRNA, which is worth approximately $0. The most recent transaction as insider was on Feb 01, 2024, when has been sold 72,768 shares (Ordinary Shares) at a price of $2.29 per share, resulting in proceeds of $166,638. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Kathleen A. Rickard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
SELL
Payment of exercise price or tax liability
$166,638 $2.29 p/Share
72,768 Reduced 2.56%
2,767,872 Ordinary Shares
Nov 03 2023
SELL
Open market or private sale
$112,803 $1.92 p/Share
58,752 Reduced 2.03%
2,840,640 Ordinary Shares
Nov 01 2023
SELL
Payment of exercise price or tax liability
$301,256 $1.74 p/Share
173,136 Reduced 5.63%
2,899,392 Ordinary Shares
Oct 20 2023
BUY
Grant, award, or other acquisition
-
200,000 Added 6.11%
3,072,528 Ordinary Shares
Aug 07 2023
SELL
Open market or private sale
$3,952 $2.47 p/Share
1,600 Reduced 0.06%
2,872,528 Ordinary Shares
Aug 04 2023
SELL
Open market or private sale
$69,860 $2.5 p/Share
27,944 Reduced 0.96%
2,874,128 Ordinary Shares
Aug 03 2023
SELL
Open market or private sale
$129,029 $2.55 p/Share
50,600 Reduced 1.71%
2,902,072 Ordinary Shares
Aug 02 2023
SELL
Open market or private sale
$35,555 $2.59 p/Share
13,728 Reduced 0.46%
2,952,672 Ordinary Shares
Aug 01 2023
SELL
Open market or private sale
$52,892 $2.68 p/Share
19,736 Reduced 0.66%
2,966,400 Ordinary Shares
May 03 2023
SELL
Open market or private sale
$76,192 $2.65 p/Share
28,752 Reduced 0.96%
2,971,136 Ordinary Shares
May 01 2023
SELL
Open market or private sale
$199,753 $2.58 p/Share
77,424 Reduced 2.52%
2,999,888 Ordinary Shares
Feb 02 2023
SELL
Open market or private sale
$72,742 $2.53 p/Share
28,752 Reduced 0.93%
3,077,312 Ordinary Shares
Feb 01 2023
SELL
Open market or private sale
$230,297 $2.56 p/Share
89,960 Reduced 2.81%
3,106,064 Ordinary Shares
Jan 20 2023
BUY
Exercise of conversion of derivative security
-
105,000 Added 3.18%
3,196,024 Ordinary Shares
Nov 01 2022
SELL
Payment of exercise price or tax liability
$90,022 $1.6 p/Share
56,264 Reduced 1.77%
3,119,776 Ordinary Shares
Nov 01 2022
SELL
Open market or private sale
$47,153 $1.64 p/Share
28,752 Reduced 0.92%
3,091,024 Ordinary Shares
Sep 26 2022
BUY
Grant, award, or other acquisition
-
800,000 Added 20.12%
3,176,040 Ordinary Shares
Aug 02 2022
SELL
Open market or private sale
$20,126 $0.7 p/Share
28,752 Reduced 1.2%
2,376,040 Ordinary Shares
Aug 01 2022
SELL
Payment of exercise price or tax liability
$37,809 $0.67 p/Share
56,432 Reduced 2.29%
2,404,792 Ordinary Shares
May 03 2022
SELL
Open market or private sale
$14,088 $0.49 p/Share
28,752 Reduced 1.15%
2,461,224 Ordinary Shares
May 01 2022
SELL
Payment of exercise price or tax liability
$29,345 $0.52 p/Share
56,432 Reduced 2.22%
2,489,976 Ordinary Shares
Apr 11 2022
SELL
Open market or private sale
$32,249 $0.54 p/Share
59,720 Reduced 2.29%
2,546,408 Ordinary Shares
Apr 08 2022
SELL
Open market or private sale
$66,552 $0.59 p/Share
112,800 Reduced 4.15%
2,606,128 Ordinary Shares
Feb 01 2022
SELL
Payment of exercise price or tax liability
$49,577 $0.78 p/Share
63,560 Reduced 2.28%
2,718,928 Ordinary Shares
Nov 01 2021
SELL
Payment of exercise price or tax liability
$36,434 $0.64 p/Share
56,928 Reduced 2.0%
2,782,488 Ordinary Shares
KAR

Kathleen A. Rickard

Chief Medical Officer
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA